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Notch signaling is an evolutionarily conserved intercellular signaling pathway that plays numerous crucial roles in vascular 
development and physiology. Compelling evidence indicates that Notch signaling is vital for vascular morphogenesis including 
arterial and venous differentiation and endothelial tip and stalk cell specification during sprouting angiogenesis and also vessel 
maturation featured by mural cell differentiation and recruitment. Notch signaling is also required for vascular homeostasis in 
adults by keeping quiescent phalanx cells from re-entering cell cycle and by modulating the behavior of endothelial progenitor 
cells. We will summarize recent advances of Notch pathway in vascular biology with special emphasis on the underlying mo-
lecular mechanisms. 
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As the most widely distributed organ in the body, blood 
vessels supply oxygen and nutrients and bring away meta-
bolic wastes. Blood vessels also support tissue growth and 
repair and provide gateways for immune surveillance. The 
abnormalities in vessel structure or function contribute to 
many diseases. Insufficient vessel growth or maintenance 
aggravates ischemic diseases such as myocardial infarction 
and stroke, whereas excessive vascularization or abnormal 
remodeling promotes many diseases including cancer, me-
tabolism-associated disorders, inflammation, and eye-  
related degenerative diseases [13].  
In early embryonic and postnatal stages, the highly orga-
nized and functionally competent vascular networks are 
progressively assembled essentially through vasculogenesis 
and angiogenesis. Vasculogenesis refers to the process of 
forming major embryonic vessels by coalescence of indi-
vidual endothelial progenitor cells (EPCs) or angioblasts 
that arise de novo from extraembryonic and embryonic lat-
eral mesoderms. These progenitors form vesicles and cords 
of attached vascular endothelial cells (ECs) that undergo 
further morphogenesis to form endothelial tubes. Angio-
genesis is defined as the formation of new vessels from 
preexisting vessels, either by sprouting and elongation of 
new vessels from the existing vessels (sprouting angiogene-
sis) or by remodeling of vessels via internal division of 
preexisting vessels in the capillary plexus (intussusceptive 
angiogenesis). Most blood vessel formation in later devel-
opmental and postnatal stages occurs via angiogenesis, 
which is halted in most adult tissues due to mature ECs 
staying in quiescence to maintain vascular homeostasis, 
except for the ovarian and the uterine epithelium during the 
menstrual cycle. In response to angiogenic signals, not only 
a part of mature ECs regain the ability of angiogenic prolif-
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eration and differentiation, but also EPCs preserved in   
the bone marrow (BM) are mobilized to contribute to  
postnatal vasculogenesis, leading to neovascularization in 
adults [2,4].  
Since the early discoveries in late 1990s demonstrating 
the essential roles of Notch signaling in physiological vas-
culature and cardiovascular disorders in Alagille syndrome, 
a Notch pathway-wired signaling network in vessel devel-
opment and function has emerged based on a large array of 
evidence from both experimental and genetic studies [57]. 
Recently, critical signaling knots and connections with other 
pathways of this network have been depicted. Moreover, 
increasing data have shown that the Notch signaling path-
way also plays a pivotal role in vascular homeostasis and 
remodeling. In this review, we will discuss the physiologi-
cal roles of Notch pathway in vascular development, 
providing an overview on the involvement of Notch signal-
ing in vascular biology ranging from morphogenesis to ho-
meostasis in the adult.  
1  The core Notch signaling pathway 
Notch signaling is an evolutionarily highly conserved path-
way mediating cell contact-dependent signaling between 
neighboring cells in metazoans [8]. Signaling mediated by 
Notch receptors and ligands is involved in the regulation of 
many developmental events, such as cell differentiation, 
proliferation and apoptosis during embryogenesis and ho-
meostasis of adult self-renewing tissues [8]. Notch signal 
may specify cell fates via lateral inhibition or induction, in 
which a cell takes a fate different from its signal-sending 
neighboring cells or is instructed to a specific fate, respec-
tively [8,9]. In mammals, there are five Notch ligands (Jag-
ged (Jag) 1 and 2 and delta-like (Dll) 1, 3 and 4) and four 
Notch receptors (Notch14), both of which are type I 
transmembrane proteins. Notch receptors are activated by 
binding to the ligands, which triggers two steps of sequen-
tial receptor cleavages within the transmembrane domain 
catalyzed by ADAM17 and -secretase, respectively. These 
cleavages result in the release of the Notch intracellular 
domain (NICD) into the cytoplasm. NICD then translocates 
into the nucleus and binds to the transcription factor CSL (C 
promoter-binding factor 1 (CBF-1)/suppressor of hairless 
(Su(H))/Lin-12 and Glp-1 (LAG-1), also known as recom-
bination signal-binding protein-J kappa (RBP-J) in rodents). 
Association of NICD and CSL replaces a corepressor com-
plex from CSL with a coactivating complex containing the 
Mastermind-like (MAML) protein, and activates the tran-
scription of downstream genes such as the Hes (Hairy and 
enhancer of split) family molecules Hey1, Hey2 [7]. Re-
cently several groups have utilized CHIP (chromatin im-
munoprecipitation) array to identify downstream effectors 
of Notch pathway [1012], discovering hundreds of direct 
downstream candidate genes of canonical Notch signaling. 
In addition, NICD has been shown to interact with many 
other signal transduction molecules to regulate cell behavior 
independent on CSL factors, constituting the non-canonical 
Notch signaling [10].  
2  Notch signaling in vessel morphogenesis 
2.1  Vasculogenesis 
The development of the vascular system begins with the 
formation of hemangioblasts, which are organized into 
blood islands in the yolk sac. Hemangioblasts at the outer 
region of blood islands form angioblastic cells, and aggre-
gate into primitive vessels after migration. Primitive vessels 
need to differentiate into a hierarchically organized network 
of arteries, capillaries, and veins. Arteries are supported by 
layers of vascular smooth muscle cells (vSMCs) and a spe-
cialized matrix, and are characterized by higher expression 
of Ephrin-B2. Veins are thinner and surrounded by fewer 
vSMCs, and are featured by expressing EphB4, the ligand 
for Ephrin-B2 [1,13,14]. The initial expression of markers 
of arterial and venous identity occurs before the initiation of 
heart beat and circulatory flow, suggesting that genetic de-
terminants rather than hemodynamic factors such as blood 
flow and pressure play a critical role in instructing the initial 
steps of arterial/venous fate determination [1]. Now it is 
clear that a variety of factors such as Notch, Hedgehog and 
Coup-TFII work in concert to specify arterial or venous  
fate [14].  
Notch pathway components are highly expressed in arte-
rial ECs but are low in veins. Intervention of Notch signal-
ing in Dll4 heterozygous mice, endothelial-specific Hes1 
and Hes5 mutant or Hey1 and Hey2 double-mutants all 
leads to loss of arterial markers and re-expression of venous 
signature genes in arterial ECs [1518]. Overexpression of 
activated Notch4 in adult mice induced EphrinB2 expres-
sion in the venous compartment. These mice were charac-
terized by arteriovenous malformation that was reversible 
after repression of Notch4 expression [19,20]. Recently, 
using transgenic zebrafish bearing a Notch reporter, 
Quillien et al. [21] have demonstrated that Notch signal is 
activated in endothelial progenitors during vasculogenesis 
prior to blood vessel morphogenesis, and that endothelial 
progenitors in which Notch signal is activated are commit-
ted to a dorsal aorta fate. Lineage analysis, together with 
perturbation of both Notch receptor and ligand function, 
further suggests several distinct developmental windows in 
which Notch signaling acts to promote artery commitment 
and maintenance. In response to Notch signaling, Ephrin- 
B2 expression increases in arterial ECs, whereas its receptor 
EphB4 in venous ECs is repressed by Notch signal [13]. 
Together, these findings demonstrate that Notch acts in dis-
tinct contexts to initiate and maintain artery identity during 
embryogenesis, partially by controlling the expression of 
Eph-Ephrin family members, which define arterio-venous 
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boundaries.  
Notch signaling is also implicated in the regulation of 
EPCs in postnatal neovascularization [2224]. Jagged1 and 
Dll1 are expressed by BM stromal niche cells and the re-
ciprocal interaction between Jagged1, but not Dll1, and 
Notch receptors on EPCs stimulates EPC commitment, dif-
ferentiation and mobilization [25]. Recently Ii et al. [26] 
have shown that Notch1 regulates EPC function and viabil-
ity during recovery from arterial injury in hypercholester-
olemic mice. With a mouse partial hepatectomy (PHx) 
model and RBP-J deficient mice, our group has shown that 
Notch-RBP-J signaling regulates the mobilization and func-
tion of endothelial progenitor cells by dynamic modulation 
of CXCR4 expression [27]. Further, we found that Notch 
signal might exert different roles in heterogenous EPC sub-
sets [28]. In a choroidal neovascularization model, RBP-J 
deficiency induced a more intensive angiogenic response to 
injury. This could be rescued by BM transplantation, indi-
cating that RBP-J could modulate BM-derived EPCs in 
adult vascularization [29]. These findings are likely to lead 
to the advancement of cell-based therapies for vascular re-
generation for ischemic vascular diseases in the future.  
2.2 Sprouting angiogenesis  
Sprouting angiogenesis involves coordinative efforts of two 
distinct EC types, namely tip and stalk cells. Tip cells pro-
trude filopodia extending to the vessel frontier and the fol-
lowing stalk cells proliferate to form the trunk of the new 
vessel sprouts [6,30]. Notch signaling plays a fundamental 
role in tip and stalk cell specification. The dynamic spatial 
and temporal expression of Dll4 helps to set up a “salt and 
pepper” pattern of tip and stalk cell distribution [30]. In 
response to VEGF stimulation, cells that have higher 
VEGFR2 signal upregulate Dll4 and adopt a tip cell fate to 
initiate sprouting [31]. Dll4 then activates the Notch path- 
way in adjacent ECs to reduce its expression of VEGFR2 
and VEGFR3, thereby suppressing the tip cell phenotype 
and alternatively promoting the stalk cell phenotype [30,31]. 
In the absence of Notch signaling, ECs continue to form 
sprouts in response to VEGF, resulting in more sprouts and 
branches per sprout, as has been documented in different 
model systems such as zebrafish embryos [32], mouse reti-
na [3335] and xenograft tumors [3638]. More recently, a 
role of Notch signaling has also been demonstrated in de-
cidual angiogenesis and luteal angiogenesis [39]. Jagged1, 
another type of Notch ligands, plays a proangiogenic role in 
mice by antagonizng Dll4-Notch signaling in cells express-
ing Fringe family glycosyltransferases (Figure 1) [34]. 
2.3  Vessel maturation  
A fundamental feature of vessel maturation is the recruit-
ment of mural cells, which consist of vSMCs and pericytes. 
Lineage mapping studies have identified vSMCs derived 
from a variety of embryonic sources such as neuronal crest, 
pericardium, mesothelium, secondary heart field, somites, 
and mesoangioblasts. Recently Chang et al. have displayed 
that a local Tie1+ CD31dimVEcad-CD45 precursor can 
differentiate into vSMCs in all vascular beds and this pro-
cess requires Notch activation [40]. Even committed skele-
tal myoblasts can be converted into functional pericytes via 
Dll4 and PDGF-BB [41].  
Notch signals on vessel endothelial cells also control 
maturation and arterial differentiation of vSMCs [42]. En-
dothelial‑specific Jagged1 mutants have impaired vSMC 
differentiation and valve morphogenesis defects in both 
embryonic and adult mice, reminiscent of Alagille syn-
drome [43,44]. While Jagged1 is the major ligand important 
for this process, Notch3 seems to be the critical receptor for 
mural cell differentiation. Notch3 is predominantly ex- 
 
 
Figure 1 (color online)  Notch pathway plays various roles in vessel morphogenesis and homeostasis. Notch pathway is dispensable for hemangioblast 
differentiation into angioblast, while is required for adult HSC self-renewal. In arterial and venous differentiation, Notch signal is fundamental for arterial 
identity and maintenance. The complex interaction between Notch and VEGFR signaling is crucial for tip and stalk cell specification. Notch signal keeps on 
working by regulating mural cell differentiation and recruitment in vessel maturation in later stages of vessel morphogenesis. Furthermore, Notch signaling 
pathway is required for adult vessel homeostasis by modulation of EPC differentiation and mobilization and maintenance of EC quiescence through p21.  
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pressed in arterial vSMCs and is not expressed in veins. 
Notch3 deletion impairs mural cell investment, resulting in 
progressive loss of vessel coverage [45,46], whereas Notch3 
mutations in humans cause degeneration of vSMCs in 
CADASIL, a human stroke and dementia syndrome [4750]. 
Up-regulation of PDGFRβ expression by Notch signal may 
contribute to Notch3-regulated mural cell investment, as 
demonstrated by Jin et al. [51]. Scheppke et al. [52] further 
documented that Jagged1 on ECs promotes the expression 
of integrin αvβ3, which facilitates vSMCs adhesion to en-
dothelial basement membrane and vessel maturation. These 
observations indicate that Jagged1 expression by ECs acti-
vates Notch signaling in neighboring cells and drives vSMC 
differentiation and maturation [53,54], possibly by inducing 
the expression of PDGFRβ and integrin αvβ3.   
A very recent study has demonstrated that Notch/ 
VEGFR-regulated differential dynamics of VE-cadherin 
junctions drive functional EC rearrangements during 
sprouting [55]. Continual flux in Notch signaling levels in 
individual cells results in differential VE-cadherin turnover 
and junctional-cortex protrusions, which drive differential 
cell movement. In cultured ECs, Notch signaling quantita-
tively reduces junctional VE-cadherin mobility. Only dif-
ferential adhesion dynamics generates long-range position 
changes, which is required for tip cell competition and stalk 
cell intercalation [55]. Computational simulation and quan-
titative image analysis of VE-cadherin junctional patterning 
in vivo have identified that differential VE-cadherin mobil-
ity is lost under pathological high VEGF conditions, such as 
retinopathy and tumour vasculature [55]. These results pro-
vide a mechanistic explanation for how cells rearrange dur-
ing normal sprouting and how rearrangement switches to 
generate abnormal vessels in pathologenesis.  
2.4  Vessel remodeling and regression 
The initial endothelial plexus created by vascular sprouting 
is a homogenous EC network, and is generated in excess. 
The final adjustment of vascular density involves the re-
gression of unnecessary vessels through vascular remodel-
ing and pruning. Blood flow is critically important for ves-
sel remodeling and regression by modulating the expression 
of shear stress-responsive transcription factor Kruppel-like 
factor 2 (KLF2), which promotes EC quiescence and the 
formation of stable vessels with an anti-thrombogenic en-
dothelial lining, while hypoperfused vessels with low KLF2 
expression may undergo apoptosis or regression instead 
[30]. Notch signaling also plays a role in vessel remodeling 
and regression. Inhibition of Notch signaling prevented 
vessel regression both in normal retinal development and in 
the oxygen-induced retinopathy model in mice [56]. Inter-
estingly, Dll4/Notch inhibition lead to increased expression 
of the vasodilator adrenomedullin and suppressed expres-
sion of the vasoconstrictor angiotensinogen in a VEGF- 
independent manner [56]. In addition, recent data have also 
demonstrated that Notch signaling in macrophages is im-
portant for their localization and interaction with ECs in 
vessel branch fusion during sprouting angiogenesis [57].  
3  Notch signaling in vessel homeostasis 
The homeostasis of the vascular structure in normal adults 
is critical for the structure and function of organ parenchy-
ma. Neovascularization in the adult retina, for instance, acts 
as a pivotal pathological process contributing to the 
age-related macular degeneration or diabetic retinopathy. 
Understanding the mechanisms governing vascular homeo-
stasis and ECs quiescence in adult organs thus has im-
portant clinical implications [7]. Using the Cre-LoxP-  
mediated conditional gene deletion, our group demonstrated 
in adult mice that disruption of RBP-J strikingly induced 
spontaneous angiogenesis in multiple tissues, including ret-
ina and cornea, as well as in internal organs, such as liver 
and lung [29]. Accumulative vessel outgrowth may result 
from significantly increased proliferation of ECs, possibly 
through upregulation of VEGFR2 expression in RBP-J de-
ficient ECs [29]. In addition, ECs in RBP-J deficient mice 
exhibit a  significant down-regulation of VEGFR1, which 
is responsible for maintaining the corneal avascularity by 
antagonizing proangiogenic factors [29]. These findings 
suggest that RBP-J-mediated Notch signaling may play an 
essential role in the maintenance of vascular homeostasis in 
adults by repressing EC proliferation.  
Liver sinusoid ECs (LSECs) are specialized ECs lining 
the surface of LSs, which function to filter serum, regulate 
hepatic microcirculation, and participate in metabolism. 
LSECs have complicated communications with hepatocytes, 
and play critical roles in supporting liver development and 
regeneration [58]. LSECs also participate in the pathogene-
sis of many liver diseases [59], such as the BM transplanta-
tion-induced veno-occlusive disease, which is characterized 
by congested LSs, fibrin deposition, subendothelial edema, 
and hepatocellular abnormalities. Conditional deletion of 
RBP-J in adult mice resulted in LSEC proliferation and a 
veno-occlusive disease-like phenotype in the liver [60]. 
Regeneration of liver after partial hepatectomy (PHx) was 
remarkably impaired, with reduced LSEC proliferation and 
destroyed sinusoidal structure [60]. These results indicated 
that Notch/RBP-J signaling may play dual roles in LSECs: 
in resting liver it represses proliferation, and in regenerating 
liver it supports proliferation and function of LSECs.  
4  Prospective 
Although we have witnessed great advances in uncovering 
the critical roles of Notch pathway in vascular development 
and homeostasis in the past decades [7,61], the current 
low-resolution picture of Notch function in vasculature pro-
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vided limited mechanistic and clinical-relevant insights, 
raising many important open questions for future studies.  
(i) The Notch pathway cross-talks with numerous other 
pathways and molecules through canonical and non-   
canonical signaling. Molecular interactions between Notch 
and other pathways should be identified to depict the mo-
lecular network governing vascular morphogenesis and ho-
meostasis. For instance, it has been shown recently that 
critical metabolism molecules and pathways are involved in 
vessel sprouting [6264]. Moreover, cell adhesive mole-
cules appear to play more and more important roles in vas-
cular development [55,65,66]. It will be interesting to elu-
cidate whether Notch signaling interacts with these path-
ways to modulate vessel morphogenesis and homeostasis. 
Identification of downstream molecules is another important 
task to explain the mechanism of Notch signaling in vessels. 
Although multiple epigenetic mechanisms have been re-
vealed in vessel development and homeostasis [67,68], their 
relationship with Notch signaling is still obscure.  
(ii) To what extent does Notch signaling regulate endo-
thelial functions? Dll4 induces Notch signaling in macro-
phages and participates in inflammation [69]. We and others 
have shown that Notch signaling participates in oxidative 
responses in both ECs and tissue parenchymal cells [70,71]. 
Moreover, it is noteworthy that Notch signaling in ECs and 
vSMCs regulates vasoreactivity of blood vessels [56]. 
Analyses of different Notch reporter mice and gene modi-
fied mice of different Notch pathway components, as well 
as comprehensive bioinformatic integration, will be helpful 
to dissect the exact role of this pathway in endothelial func-
tions [72].  
(iii) Notch signaling in vessel-related diseases will be 
another research hot-point in this field. Genetic and animal 
model studies have identified mutations of Notch signaling 
as etiological reasons of a few human diseases, including 
Cadasil syndrome [73], Alagile syndrome [74], familial 
tetralogy of Fallot [75], and so on. Notch activation is also 
implicated in EC senescence and pro-inflammatory re-
sponse [76], which might involve the SIRT1 deacetylase 
[77]. Dll4 blockade attenuates atherosclerosis and metabolic 
disorders [78]. Furthermore, given the central roles of Notch 
in the development and homeostasis of vascular morpho-
genesis and homeostasis, Notch is long regarded as a highly 
desirable therapeutic target from a translational perspective 
[79]. We have invented an EC-targeted soluble human Dll1 
and evaluated its effects on suppressing tumor angiogenesis 
[80]. A more comprehensive understanding of Notch signal 
in vascular biology may lead to better therapeutic strategies 
to control angiogenesis in relevant diseases. 
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